|
| | | | | Logomix raises $19M to accelerate cellular system engineering for drug discovery in the U.S.
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Marea Therapeutics enrolls first participant in Phase 1 clinical study evaluating MAR002 for Acromegaly
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Siolta Therapeutics has been awarded a $1.8 million Direct-to-Phase II SBIR grant from the National Institute of Allergy and Infectious Diseases (NIAID) to advance their mixed-strain live biotherapeutic for recurrent bacterial vaginosis
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | OneSkin announces $20M Series A Investment from Prelude Growth Partners to accelerate the future of skin longevity
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Tahoe Therapeutics raises $30M to build AI models of living cells
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | | Therna Biosciences launches with proprietary generative AI models for designing programmable RNA medicines
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Ruby Bio collaborates with Advanced Biofuels and Bioproducts Process Development Unit (ABPDU) at Lawrence Berkeley National Laboratory for the initial scale-up of their naturally derived biosurfactants
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | MBC BioLabs and Gilson partner to provide resident companies with advanced technologies, training and streamlined workflows that accelerate research and innovation
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | | | Founders at Work: Tahoe Bio
Building Frontier Datasets to Power the Virtual Cell
September 4 @ 12-1pm
135 Mississippi St, San Francisco
Please join us for our upcoming Founders at Work Speaker Series featuring Johnny Yu, co-founder and CSO at Tahoe Therapeutics.
Generation of large scale single-cell datasets are now integral to the vision of the virtual cell. At Tahoe, we are leading a generation of frontier scale datasets across diverse perturbations to i) develop programs from unbiased datasets ii) enable modeling of the cell states.
REGISTER ► |
|
| Agilent Lunch & Learn
September 11 @ 12-1pm
930 Brittan Ave, San Carlos
Discover practical strategies for intact biomolecule analysis — from small vs. large molecule approaches to chromatography (SEC, RPC, HIC) and mass spectrometry applications. Led by Agilent experts Andrea Ngai, Bita Parvizian, and Natalie Rasmussen. Registration required.
REGISTER ► |
|
| Biologics & Brews with ThermoFisher Scientific
September 10 @ 10am-12pm
1030 Brittan Ave, San Carlos
September 11 @ 4:30-7pm 135 Mississippi St, San Francisco
REGISTER ►
You’re invited to Biologics and Brews with ThermoFisher! Pick between a laid-back brunch or a lively happy hour. Each event will be hosted at a different MBC BioLabs location and feature great food, drinks, and meaningful conversations about the future of biologics and drug development. |
|
| Data Bites: Lunch & Learn with CDD
September 18 @ 12-1pm
1030 Brittan Ave, San Carlos
Join CDD Vault and MBC BioLabs resident Nathan Shapiro (Medicinal Chemist at Pallando Therapeutics, 733 Industrial Rd) for a session on how CDD Vault's centralized data management and analysis platform can help streamline your workflow, centralize project knowledge, and accelerate collaborative research.
REGISTER ► |
|
| MBC BioLabs Oncology Innovation Forum
September 18 @ 3:30-7:30pm
1030 Brittan Ave, San Carlos
We’re excited to host our third Innovation Forum, spotlighting breakthrough oncology startups and bringing together a curated group of investors, industry leaders, and MBC BioLabs founders.
This invitation-only event will feature investor insights, startup presentations from companies like Alessa Therapeutics, DeepSeq.AI, and Serna Bio, a poster session showcasing emerging technologies, and a networking reception with leaders across the life sciences ecosystem.
REGISTER ► |
|
| MBC BioLabs Life Science Vendor Showcase
September 23 @ 11am-2pm
1030 Brittan Ave, San Carlos
Join us at 1030 Brittan Ave for our next Life Science Vendor Showcase — a casual, drop-in expo featuring top vendors, live demos, and plenty of chances to network. Lunch will be provided!
- Meet vendors & explore new workflows. - Get practical tips tailored to your research. - Connect with the local life science community.
REGISTER ► |
|
| Founders at Work: Alpine BioEstablishing Plants as the Third Pillar of Biomanufacturing: From Idea to Product
September 24 @ 12-1pm
135 Mississippi St, San Francisco
Our second Founders at Work speaker this month is Magi Richani, Founder & CEO of Alpine Bio and an MBC BioLabs alum.
Magi will share her journey of establishing plants as the “third pillar” of biomanufacturing, alongside microbial fermentation and cell culture. From an idea sparked by cheese to building a molecular farming company, she’ll walk us through the scientific breakthroughs, entrepreneurial challenges, and unique advantages of turning plants into sustainable protein factories.
REGISTER ► |
|
| Refeyn Mass Photometry User Group Meeting
October 1 @ 9am-5pm
135 Mississippi St, San Francisco
Join us for a full-day, in-person meeting hosted by Refeyn. Expect user talks, practical workflows, networking, and interactive demos—plus a poster session with refreshments—designed for both current users and those curious to learn more.
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
| | MEET OUR NEWEST RESIDENTS |
|
| | | Onava is building an AI-enabled, lab-in-the-loop platform for antibody discovery and optimization. By tightly integrating generative AI/ML models, high-throughput wet lab assays, and expert-driven engineering, Onava accelerates the design of functional, biologically relevant antibody candidates. The platform is purpose-built to rapidly ingest experimental data with minimal preprocessing, enabling fast model refinement and active learning cycles that improve real-world therapeutic outcomes.
We warmly welcome co-founders Sharrol Bachas (CSO) and Ido Calman (CEO) to our 1030 Brittan community in San Carlos!
LEARN MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Cornucopia Biosciences is building the world’s first fully automated, AI-native contract research organization (CRO). Scientists can run assays with a simple prompt, and experiments are executed 24/7 with speed, accuracy, and reproducibility. By lowering costs and turnaround times, Cornucopia accelerates preclinical research while reducing reliance on animal testing.
We are excited to welcome CEO Himay (Mickey) Makhija and CTO Raunak Anand to our 1030 Brittan community in San Carlos!
LEARN MORE ► |
|
| | | | |
|
|
|
| |
|
